|Bid||14.69 x 800|
|Ask||14.76 x 900|
|Day's Range||14.51 - 14.74|
|52 Week Range||9.97 - 16.40|
|Beta (3Y Monthly)||0.75|
|PE Ratio (TTM)||20.84|
|Earnings Date||Nov 7, 2019 - Nov 11, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.00|
GREENVILLE, S.C., Sept. 24, 2019 /PRNewswire/ -- eRAD, a subsidiary of RadNet, Inc. (RDNT), a leading provider of standards-based, web-centric radiology image and data management solutions, announced today that Solis Mammography has deployed eRAD RIS in 65 centers across six states. As the nation's largest independent provider of breast screening and diagnostic services, Solis Mammography has sites in Pennsylvania, Arizona, Colorado, North Carolina, Ohio, and Texas—including freestanding mammography centers and hospital partnerships. It also serves the DC metropolitan area through its affiliated brand, Washington Radiology, a multi-modality medical imaging provider with a 70-year history of care.
LOS ANGELES, Sept. 24, 2019 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of.
GREENVILLE, S.C., Sept. 10, 2019 /PRNewswire/ -- eRAD announced today that its healthcare communication platform, RADAR, sent more than 1.2 million secure messages in the month of July. RADAR was developed to facilitate faster communication between physicians—and to patients. It provides streamlined delivery, receipt, and confirmation of any type of healthcare communication—from patient reminders and surveys to critical test results and lab work for referring physicians.
Improves the ability to diagnose neurological conditions. NEWARK, Del., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Delaware Imaging Network (DIN), Delaware’s largest network of outpatient medical imaging centers, which is a division of RadNet, Inc. (RDNT), a national leader in providing high-quality, cost-effective, outpatient diagnostic imaging services, has added NeuroQuant, a FDA-cleared MRI software used in the assessment of neurological conditions, to brain imaging studies at all its centers that offer MRI services.
RadNet (RDNT) delivered earnings and revenue surprises of -16.67% and 6.56%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Revenue increased 18.3% to $289.1 million in the second quarter of 2019 from $244.4 million in the second quarter of 2018Adjusted EBITDA(1) increased 13.0% to $43.1 million.
RadNet, Inc. (RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has created a division to further its efforts in Artificial Intelligence (“A.I.”). In conjunction with this, RadNet reports it has acquired the 75% that it did not already own of Nulogix, Inc., an early stage company focused on creating A.I. solutions for the radiology industry. RadNet’s newly created A.I. division will focus on developing, acquiring and investing in technologies that focus on image interpretation and radiology business processes. In addition to internally developing A.I. solutions through its newly acquired Nulogix team, RadNet will evaluate partnering, licensing and investing in A.I. solutions developed by others.
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LOS ANGELES, July 23, 2019 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned.
Read the beginning of this article here. The most valuable position in Moab Capital Partners’ portfolio at the end of Q1 2019 was in Viad Corp (NYSE:VVI) worth $82.05 million, on the basis of 1.46 million shares outstanding. This position comprised 19.45% of the fund's portfolio. Viad Corp is an S&P SmallCap 600 company that […]
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]
NEWARK, Del., June 21, 2019 -- Delaware Imaging Network (DIN) has announced personalized breast cancer risk assessment during annual mammographic screenings. DIN, a wholly.
LOS ANGELES, June 05, 2019 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of.
LOS ANGELES, June 03, 2019 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of.
RadNet (RDNT) delivered earnings and revenue surprises of 0.00% and 6.05%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?